Filing Details

Accession Number:
0001181431-13-042815
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-05 16:43:41
Reporting Period:
2013-08-05
Filing Date:
2013-08-05
Accepted Time:
2013-08-05 16:43:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1533040 Rxi Pharmaceuticals Corp RXII Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304395 J Robert Bitterman C/O Rxi Pharmaceuticals Corporation
1500 West Park Drive, Suite 210
Westborough MA 01581
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Acquisiton 2013-08-05 500 $4.13 500 No 4 P Direct
Common Stock, Par Value $0.0001 Acquisiton 2013-08-05 200 $4.05 700 No 4 P Direct
Common Stock, Par Value $0.0001 Acquisiton 2013-08-05 100 $4.01 800 No 4 P Direct
Common Stock, Par Value $0.0001 Acquisiton 2013-08-05 100 $4.02 900 No 4 P Direct
Common Stock, Par Value $0.0001 Acquisiton 2013-08-05 100 $4.05 1,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct